GUARDANT HEALTH has partnered with SWOG on a study to use cell-free DNA testing to identify mechanisms of resistance and future treatment options in non-small cell lung cancer. SWOG chose Guardant360 as the blood test for a tumor genomic profiling study of approximately 600 lung cancer patients. The study will test patients at the time...
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
